Skip to main content
Mehow Innovative Ltd. logo

Mehow Innovative Ltd. — Investor Relations & Filings

Ticker · 301363 ISIN · CNE100005WP6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 498 across all filing types
Latest filing 2024-04-17 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 301363

About Mehow Innovative Ltd.

https://www.mehow.com

Mehow Innovative Ltd. specializes in the design, development, and manufacturing of high-precision medical devices and components. The company focuses on advanced manufacturing technologies, particularly Liquid Silicone Rubber (LSR) molding, multi-shot injection molding, and precision plastic components. Its core product portfolio includes respiratory care solutions, drug delivery systems, surgical instruments, and specialized medical consumables. Mehow provides comprehensive contract development and manufacturing organization (CDMO) services, encompassing product design, mold engineering, and automated assembly within controlled cleanroom environments. By integrating material science with precision engineering, the company supports global medical device manufacturers in producing complex, high-performance components for critical healthcare applications.

Recent filings

Filing Released Lang Actions
东兴证券关于深圳市美好创亿医疗科技股份有限公司2023年度定期现场检查报告
Audit Report / Information Classification · 95% confidence The document is titled as a '2023年度定期现场检查报告' which translates to '2023 Annual Regular On-site Inspection Report' for Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. It is issued by Dongxing Securities Co., Ltd. The content includes detailed inspection items such as corporate governance, internal control, information disclosure, related party transactions, use of raised funds, performance, and other important matters. The document contains substantive findings and opinions on these areas, indicating it is a comprehensive inspection report rather than a brief announcement or certification. The length is over 5,000 characters and it contains detailed substantive content rather than just a notice or summary. This type of document aligns most closely with an Audit Report / Information (AR) as it involves regulatory on-site inspection results and compliance checks, which are typical of audit or regulatory inspection reports. It is not an Annual Report (10-K), Interim Report (IR), or other categories such as Management Reports or Regulatory Filings because it is a specific inspection report with detailed findings. Therefore, the best classification is AR (Audit Report / Information).
2024-04-17 Chinese
关于召开2023年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2023 Annual General Meeting (AGM) of Shenzhen Meihow Medical Technology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including approval of the 2023 annual report, board and supervisory reports, financial statements, profit distribution, and other corporate matters. It also contains attachments such as proxy forms, registration forms, and legal representative certificates. The document is primarily an announcement and invitation to shareholders to attend and vote at the AGM, rather than the actual annual report or financial statements themselves. The length is over 6,000 characters, but the content is focused on the meeting logistics and agenda, not the report content. Therefore, it fits the category of AGM Information (AGM-R).
2024-04-17 Chinese
关于开展外汇套期保值业务的可行性分析报告
Regulatory Filings Classification · 90% confidence The document is a detailed feasibility analysis report regarding the company's plan to conduct foreign exchange hedging business. It discusses the purpose, necessity, business scope, risk analysis, risk control measures, accounting principles, and impact on daily operations. The document is not a financial report like an annual or interim report, nor is it an announcement of voting results or a regulatory filing. It is a specific business activity report focusing on the feasibility and risk management of foreign exchange hedging. This type of document does not fit into categories like earnings release, capital update, or management report. Given the nature of the content, it aligns best with a Regulatory Filings (RNS) category as a general regulatory announcement or compliance document that does not fit other specific categories.
2024-04-17 Chinese
关于使用部分闲置募集资金和自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Mehao Chuangyi Medical Technology Co., Ltd. regarding the use of temporarily idle raised funds and own funds for cash management. It details the investment types, amounts, risk analysis, approvals by the board and supervisory committee, and the sponsor's verification opinion. The document is a formal disclosure about the company's financing and cash management activities, including the use of idle funds from fundraising proceeds. It does not contain financial statements or detailed financial performance data. It is not a full annual or interim report, nor an earnings release or audit report. It is a regulatory announcement about capital/financing activities related to the use of funds. The document length is 4561 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-04-17 Chinese
关于公司2023年度证券与衍生品投资情况的专项报告
Regulatory Filings Classification · 95% confidence The document is a special report on the company's securities and derivatives investment situation for the year 2023. It includes details about approvals, investment amounts, risk analysis, and risk control measures related to foreign exchange hedging activities. The document is an announcement of the company's investment activities and compliance with regulatory requirements, rather than a full financial report or audit. It is relatively short (2013 characters) and serves as a regulatory disclosure about specific investment activities and risk management. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-04-17 Chinese
2023年年度审计报告
Regulatory Filings
2024-04-17 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.